115 related articles for article (PubMed ID: 4751995)
1. Prevention of the hepatotoxic effects of D-galactosamine by D-galactose.
Mészáros K; Antoni F; Hrabák A; Szikla C; Garzó T; Tompa A; Lapis K
FEBS Lett; 1973 Sep; 35(1):1-3. PubMed ID: 4751995
[No Abstract] [Full Text] [Related]
2. Effects of D-galactosamine on nucleotide metabolism and on microsomal membranes in mouse liver.
Mészáros K; Antoni F; Mandl J; Hrabák A; Garzó T
FEBS Lett; 1974 Aug; 44(2):141-5. PubMed ID: 4418742
[No Abstract] [Full Text] [Related]
3. The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.
Konishi Y; Shinozuka H; Farber JL
Lab Invest; 1974 Jun; 30(6):751-6. PubMed ID: 4835601
[No Abstract] [Full Text] [Related]
4. Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injury.
Holstege A; Anukarahanonta T; Yamamoto M; Koch HK; Kattermann R; Lesch R; Keppler D
Exp Mol Pathol; 1981 Apr; 34(2):170-82. PubMed ID: 6162676
[No Abstract] [Full Text] [Related]
5. Selective uridine triphosphate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. Effect on ribonucleic acid synthesis.
Keppler DO; Pausch J; Decker K
J Biol Chem; 1974 Jan; 249(1):211-6. PubMed ID: 4809627
[No Abstract] [Full Text] [Related]
6. Ultrastructural study of liver cell injury due to UTP deficiency.
Shinozuka H
Virchows Arch B Cell Pathol; 1974 Mar; 15(2):119-30. PubMed ID: 4212499
[No Abstract] [Full Text] [Related]
7. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
Bauer C; Reutter W; Bachmann W; Lesch R
Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
[No Abstract] [Full Text] [Related]
8. 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo.
Schiessel C; Forsthove C; Keppler D
Hepatology; 1984; 4(5):855-61. PubMed ID: 6207090
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of induction of rat liver tyrosine aminotransferase by D-galactosamine.
Reynolds RD; Reutter W
J Biol Chem; 1973 Mar; 248(5):1562-7. PubMed ID: 4144390
[No Abstract] [Full Text] [Related]
10. Nucleotide contents of ascites hepatoma cells and their changes induced by D-galactosamine.
Keppler DO; Smith DF
Cancer Res; 1974 Apr; 34(4):705-11. PubMed ID: 4360835
[No Abstract] [Full Text] [Related]
11. Biosynthesis of cytidine nucleotides in rat liver after administration of D-galactosamine.
Seifert J; Buchar E
Chem Biol Interact; 1981 May; 35(2):217-28. PubMed ID: 6163566
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
James GW; Pickering RW; Parker FL
Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
[TBL] [Abstract][Full Text] [Related]
13. Effects of 17 beta-estradiol on the incorporation of pyrimidine nucleotide precursors into nucleotide pools and RNA in the mouse uterus.
Miller BG; Baggett B
Endocrinology; 1972 Mar; 90(3):645-56. PubMed ID: 5009344
[No Abstract] [Full Text] [Related]
14. Galactosamine induced liver injury.
Decker K; Keppler D
Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
[No Abstract] [Full Text] [Related]
15. Modification of D-galactosamine-induced liver injury in the rat by spironolactone.
Mihas AA; Foster MM; Barnes S; Mihas TA; Hirschowitz BI; Spenney JG
Pharmacology; 1979; 18(5):235-40. PubMed ID: 482344
[TBL] [Abstract][Full Text] [Related]
16. Effect of nutritive state and precursor dose on the incorporation of orotic acid and uridine into kidney and liver of normal, castrated and, and androgen-treated mice.
Kochakian CD; Dubovsky J; Broulik P
Endocrinology; 1972 Feb; 90(2):531-7. PubMed ID: 5009336
[No Abstract] [Full Text] [Related]
17. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glucuronide formation by D-galactosone or D-galactosamine in isolated hepatocytes.
Ullrich D; Bock KW
Biochem Pharmacol; 1984 Jun; 33(11):1827-30. PubMed ID: 6732846
[No Abstract] [Full Text] [Related]
19. Inhibition of protein synthesis in rat liver by D-galactosamine.
Anukarahanonta T; Shinozuka H; Farber E
Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):481-91. PubMed ID: 4699479
[No Abstract] [Full Text] [Related]
20. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.
Decker K; Keppler D
Rev Physiol Biochem Pharmacol; 1974; (71):77-106. PubMed ID: 4375846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
